Jason Mills

Stock Analyst at Canaccord Genuity

(3.14)
# 977
Out of 4,667 analysts
115
Total ratings
75%
Success rate
43.31%
Average return

Stocks Rated by Jason Mills

TransMedics Group
Oct 29, 2024
Maintains: Buy
Price Target: $169$109
Current: $80.43
Upside: +35.52%
Penumbra
Oct 16, 2024
Maintains: Buy
Price Target: $176$235
Current: $240.46
Upside: -2.27%
STAAR Surgical Company
Apr 26, 2022
Maintains: Buy
Price Target: $81$89
Current: $26.58
Upside: +234.90%
AngioDynamics
Jul 14, 2021
Maintains: Hold
Price Target: $24$28
Current: $6.90
Upside: +305.80%
iRhythm Technologies
Nov 6, 2020
Maintains: Buy
Price Target: $236$273
Current: $74.49
Upside: +266.52%
Merit Medical Systems
Oct 29, 2020
Maintains: Buy
Price Target: $51$55
Current: $105.26
Upside: -47.75%
Neuronetics
Oct 26, 2020
Maintains: Buy
Price Target: $4$8
Current: $0.82
Upside: +874.78%
Nevro
Aug 6, 2020
Maintains: Buy
Price Target: $116$153
Current: $4.38
Upside: +3,393.15%
LeMaitre Vascular
Jul 24, 2020
Maintains: Hold
Price Target: $28$30
Current: $105.17
Upside: -71.47%
Intuitive Surgical
Jul 22, 2020
Maintains: Buy
Price Target: $187$242
Current: $550.33
Upside: -56.09%
Maintains: Hold
Price Target: $66$50
Current: $51.16
Upside: -2.26%
Maintains: Buy
Price Target: $41$45
Current: $36.06
Upside: +24.81%
Maintains: Buy
Price Target: $85$62
Current: $15.44
Upside: +301.55%
Maintains: Buy
Price Target: $43$46
Current: $91.55
Upside: -49.75%
Upgrades: Buy
Price Target: n/a
Current: $84.58
Upside: -
Downgrades: Hold
Price Target: $516,000$120,000
Current: $0.77
Upside: +15,584,315.58%